Recent pre-clinical advancements in nuclear medicine: pioneering the path to a limitless future
W Echavidre, D Fagret, M Faraggi, V Picco… - Cancers, 2023 - mdpi.com
Simple Summary This review summarizes recent advances in the nuclear medicine
theranostic approach. It covers the repurposing of historical radiotracers for new indications …
theranostic approach. It covers the repurposing of historical radiotracers for new indications …
Production of innovative radionuclides for medical applications at the CERN-MEDICIS facility
C Bernerd, JD Johnson, E Aubert, M Au… - Nuclear Instruments and …, 2023 - Elsevier
Since its commissioning in December 2017, the CERN-MEDICIS facility has been providing
non-conventional radionuclides for research in nuclear medicine. Benefitting from decades …
non-conventional radionuclides for research in nuclear medicine. Benefitting from decades …
153 Sm-labeled Fe 3 O 4@ lapatinib nanoparticles as a potential therapeutic agent for breast cancer: synthesis, quality control, and in vivo evaluation
TM Pham, DV Cao, HHQ Dang, PMT Mai… - Journal of Materials …, 2024 - pubs.rsc.org
The present study introduces Fe3O4-coated lapatinib-labeled 153Sm nanoparticles
(denoted as Fe3O4@ lapatinib-153Sm) as a promising avenue for advancing breast cancer …
(denoted as Fe3O4@ lapatinib-153Sm) as a promising avenue for advancing breast cancer …
[PDF][PDF] Tuning oxidation states of terbium and europium towards high purity terbium-161 and samarium-153 for medical applications
MO Arman, K Binnemans, T Cardinaels - 2023 - roma.sckcen.be
Today, cancer is still a leading cause of death worldwide, and according to the World Health
Organization (WHO), nearly 10 million deaths were caused by cancer in 2020, which is one …
Organization (WHO), nearly 10 million deaths were caused by cancer in 2020, which is one …